drugset / Trial / NCT00003171
Bryostatin 1 in Treating Patients With Myelodysplastic Syndrome
Treatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of bryostatin 1 in treating patients with myelodysplastic syndrome.
Timeline
- Start
- 1998-05
- Primary completion
- 1999-07
- Completion
- 2003-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | bryostatin 1 | Small molecule | — | — |